rHEALTH Technology Issued New Patent For Optical Block
CAMBRIDGE, Mass., December 5, 2017 – rHEALTH LLC announced today the issuance of a new U.S. patent for innovations in optical systems engineering, filed by DNA Medicine Institute (DMI). This advancement highlights the portability and unique measurement capabilities of the rHEALTH digital diagnostic platform, representing the miniaturization and automation of traditional laboratory testing for point-of-care applications.
The U.S. Patent and Trademark Office has granted Patent Number 9,835,542, “Optical Block,” covering a highly portable, compact, integrated diagnostic system designed to measure cells and particles. The innovative combination of lasers, detectors, flow channels, lenses, and electronics enables precise and quantitative biomedical measurements.
“We are thrilled with this latest patent issuance, which protects a core aspect of our diagnostic technology,” said Dr. Eugene Y. Chan, Founder and CEO. “This patent ensures that our platform can deliver accurate, precise, and quantitative results at the point-of-care.”
This patent further expands DMI and rHEALTH’s intellectual property portfolio, underscoring their commitment to advancing portable diagnostics and monitoring technologies for better healthcare.
About rHEALTH
rHEALTH is a digital health solutions company creating integrated technologies that transform healthcare. Its innovations include:
rHEALTH Diagnostic Platform – enables multiple laboratory tests from a single small-volume blood sample for point-of-care use.
SKYE Sensor – a wireless wearable providing real-time vital sign monitoring.
CHAS – a user-friendly mobile application supporting health management.
For more information, visit www.rhealth.com.
About DNA Medicine Institute
DNA Medicine Institute (DMI) is a biomedical incubator focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Supported by NASA, NIH, and the Bill & Melinda Gates Foundation, DMI leverages interdisciplinary science and engineering expertise to solve complex biomedical challenges.
For more information, visit www.dnamedinstitute.com.
Media Contact:
Lillian Li
(617) 913-7630
pr@rhealth.com